Clinical Trials Logo

Filter by:
NCT ID: NCT01527097 Withdrawn - Psoriasis Clinical Trials

Influence of Atorvastatin on Psoriasis Severity and Endothelial Function

Start date: August 2012
Phase: Phase 3
Study type: Interventional

Patients with psoriasis seem to have increased risk for developing atherosclerosis. This may be due to the fact that psoriasis and atherosclerosis are both caused by inflammation and involvement of cells of the immune system. Atherosclerosis is frequently treated by statins (class of cholesterol lowering drugs), which lower bad cholesterol levels and also reduce inflammation. Some new evidences also suggest that therapy with statins may improve psoriasis skin disease. The current study aims are to evaluate whether a strong statin named Atorvastatin can improve psoriatic skin disease and functioning of the arteries. The study also aims to evaluate if the activity of these two diseases are related to levels of common inflammatory biomarkers (substance in blood) and whether Atorvastatin can change their levels.

NCT ID: NCT01526369 Completed - Clinical trials for Metastatic Breast Cancer

A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer

TH V THL
Start date: February 13, 2012
Phase: Phase 3
Study type: Interventional

The proposed phase III randomised trial will compare the efficacy of trastuzumab and paclitaxel with trastuzumab, paclitaxel and lapatinib in first line treatment of HER2 positive metastatic breast cancer. The investigators will also examine potential predictive biomarkers of response to trastuzumab and lapatinib in pre-treatment biopsy samples and serum samples.

NCT ID: NCT01526057 Completed - Clinical trials for Rheumatoid Arthritis

A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)

REFLECTIONS
Start date: March 20, 2012
Phase: Phase 2
Study type: Interventional

In this study, patients with moderate to severe rheumatoid arthritis who are being treated with methotrexate will receive 2 intravenous treatments with either PF-05280586 or Rituxan (Rituximab) or MabThera (Rituximab). During the course of the study, the effects of the drugs will be assessed by sampling the levels of drug in the blood, blood cell counts, and by comparing these levels among the different treatments. Safety, tolerability and immunologic response also will be evaluated throughout.

NCT ID: NCT01525784 Not yet recruiting - Clinical trials for Type 1 Diabetes Mellitus

Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients

Start date: February 2012
Phase: N/A
Study type: Observational

The incidence of Type 1 Diabetes Mellitus is increasing annually, in all pediatric age groups, especially among infants and toddlers.However, only 30% of diabetic children manage to achieve and maintain glycated hemoglobin A1c (HbA1c) levels below 8%, although most are treated by intensive insulin therapy.Recently, devices for real-time continuous glucose monitoring (RT-CGMS) have been introduced to aid self management of glycemic control. These devices enable the patients to see the interstitial glucose levels continuously, the trends of decrement and increment, and to have alarms prior to a severe hypoglycemic episode . The RT-CGMS was approved in Israel for routine usage in the pediatric population, 0-18 years in 2011, indicated for those with recurrent hypoglycemic episodes. So, the aim of the investigators study is to examine prospectively the short and long term effect of the RT-CGMS routine usage, in daily routine life of the diabetic child.

NCT ID: NCT01524718 Not yet recruiting - Clinical trials for Fracture Neck of Femur

Internal Fixation of Hip Fractures Using Intraoperative Simultaneous Two Axis View

Start date: September 2012
Phase: N/A
Study type: Interventional

Hip fractures are one of the most frequent operated fractures procedures in orthopedics, with a world wide annual incidence of approximately 1.7 million. These fractures are associated with substantial morbidity and mortality. As populations age and life expectancy increases worldwide, the incidence of these fractures is likely to raise, expected to triple in the next 50 years. The use of fluoroscopy and resultant exposure to radiation, is an integral part of surgical procedures aiming to reduce and fixate the fractured femur. The risk of contracting cancer is significantly higher for an orthopedic surgeon as Hip surgery is a major slice of the total radiation dose. Optimal positioning and control of the imaging intensifier device may result in significant reduction of radiation dose and time and in substantial shortening of the procedure. The investigators hypothesis is that this technique would substantially shorten procedure time and reduce unnecessary radiation exposure for both the patient and the medical staff. Furthermore, by using this technique the investigators can eliminate the need for fluoroscopy technician during the surgery, as there is no need to alternate fluoroscopy views.

NCT ID: NCT01524419 Not yet recruiting - Mother (Person) Clinical Trials

Women's Involvement In Decision Making At Labor And Its Effect on Their Perceived Labor Process

Start date: March 2012
Phase: N/A
Study type: Observational

1. Increased women's involvement in decision making at labor process correlates with a positive perception of the labor process. 2. Increased maternal satisfaction with midwifery and gynecological care at labor correlates with a more positive perception of the labor process.

NCT ID: NCT01524276 Recruiting - Clinical trials for Coronary Artery Disease

Product Surveillance Registry

PSR
Start date: January 2012
Phase:
Study type: Observational

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

NCT ID: NCT01524107 Recruiting - Clinical trials for Urgent Caesarian Section Secondary to Cord Prolapse

Complications: Urgent C Section VS Elective C Section

Start date: January 2012
Phase: N/A
Study type: Observational

The medical literature does not provide sufficient information or recommendation regarding specific antibiotic coverage for urgent Caesarian sections. The goal of this study is to compare maternal and neonatal morbidity of women who have undergone urgent Caesarian Sections for Prolapsed Cord to those who have undergone Elective Caesarian Sections in order to develop a standard treatment protocol. The Medical Record review will include many parameters including complications, type of antibiotic usage etc.

NCT ID: NCT01522651 Completed - Atrial Fibrillation Clinical Trials

Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation

HARMONY
Start date: January 24, 2012
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the effect of ranolazine and of low-dose dronedarone when given alone and in combination at different dose levels on atrial fibrillation burden (AFB) over 12 weeks of treatment. AFB is defined as the total time a participant is in atrial tachycardia/atrial fibrillation (AT/AF) expressed as a percentage of total recording time.

NCT ID: NCT01522183 Recruiting - Clinical trials for Atypical Hemolytic-Uremic Syndrome

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

Start date: April 30, 2012
Phase:
Study type: Observational [Patient Registry]

Post-marketing safety data on patients treated and untreated with eculizumab or ravulizumab.